Summary Unfed plateau-phase cultures of Chinese hamster V79-cells were treated for 1 h with various amounts of adriamycin in the range between 0 and 10 gml-l and subsequently either immediately trypsinized and plated to assay for survival, or reincubated in medium collected from replicate plateau-phase cultures and returned to the incubator for various periods of time before plating. Significantly less killing was observed, for the same adriamycin dose, in cells treated in the plateau-phase and plated immediately thereafter as compared to cells treated while actively growing. When cell trypsinization and plating was delayed for up to 22h, a significant increase in killing was observed, and the survival curve obtained approached that observed after treatment with adriamycin of growing cells. Initially almost expdnential kinetics were observed for this potentiation of adriamycin-induced cell killing with a t37 of -2h. Cell survival was still decreasing after 22h of post-treatment incubation in the plateau phase, with no clear indication for approaching a plateau. However, longer incubations, to establish a plateau, were not possible due to degeneration of the cultures. Flow cytometry measurements of the intracellular adriamycin content showed only a small difference between exponentially growing and plateau-phase cells despite the significant differences in the number of cells per culture at the time of treatment. The rate at which adriamycin-related fluorescence decayed after adriamycin treatment was slightly higher for cells trypsinized and exposed to fresh medium than for cells kept in the plateau-phase. The results indicate the importance of the physiological state and the post-treatment incubation conditions of cells for the final effect of adriamycin on survival.
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Much higher doses of adriamycin are usually required to achieve the same extent of killing in plateau-phase than in actively growing cell populations (Barranco, 1975; Barranco & Noval, 1974; Twentyman & Bleehen, 1975; Sutherland, et al., 1979; Martin & McNally, 1980; Chambers et al., 1984) . This decrease in the adriamycin killing effect was partly attributed to the differences pertaining to the numbers of cells per culture during treatment in exponentially growing vs. plateau-phase cells, and it was found to decrease or disappear when cell survival was plotted against the amount of adriamycin per cell (Sutherland et al., 1979; Chambers et al., 1984) . Examination of the intracellularly accumulated amount of adriamycin, however, indicatect a significantly lower killing effect in plateau-phase cells for similar intracellular drug accumulation (Chambers et al., 1984) , suggesting that the distinct physiological state of cells in the plateau-phase may significantly affect adriamycin-induced cell killing (Barranco 1975; Twentyman & Bleehen, 1975; Martin & McNally, 1980) . Plateau-phase cultures have been proposed to be an in vitro model describing a tumour more closely than actively growing cultures (Hahn & Little, 1972) , and cells at this physiological condition were found to have increased ability to repair radiation-induced damage, if a few hours are allowed to elapse between irradiation and subculture (delayed plating, DP) (Hahn & Little, 1972; Iliakis & Pohlit, 1979) . A similar repair activity was also observed after irradiation of experimental tumours in vivo (Hahn et al., 1974) .
In this work we report the survival modifications observed after exposure of plateau-phase cells to adriamycin followed by either immediate (IP) or delayed (DP) plating. Delayed-plating protocols mimic the tumour situation more closely than immediate-plating protocols since in vivo cells are not transferred to a 'new' environment after treatment. Contrary to the results obtained under similar conditions after exposure to ionizing radiation, delayed plating of cells resulted in a dramatic potentiation of the adriamycin mediated killing, and caused plateau-phase cells to respond to treatment similarly to actively growing cells.
Materials and methods
For the experiments, Chinese hamster V79-cells G. ILIAKIS et al.
(S 171) were used. Details about their origin and growth conditions have been published (Iliakis, 1985 Adriamycin (Sigma) was given to the cells from a lmgml-l water solution and was allowed to act for 1 h (37°C). After this time period, the medium was removed from the dishes and cells were rinsed twice with phosphate buffered saline. Subsequently, one set was returned to the incubator after addition of 5 ml medium gained from replicate plateau-phase cultures after filtration to remove viable cells, and one set was trypsinized and plated. Trypsinization and plating of the set of cultures that were returned to pre-treatment conditions were carried out at various times after treatment depending on the experimental protocol. The trypsinization was performed with 0.5% trypsin and 0.2% EDTA for 15min, but it was shortened to 5min (enough to cause complete detachment of the cells from the dishes) when flow cytometry measurements of intracellular, adriamycin-related fluorescence were to follow. Cells were plated to form colonies in two 60 mm tissue culture dishes and were incubated at 37°C for 6-7 days. Twenty-five to 200 colonies were counted per dish, the standard errors of counting in the estimation of cell survival thus being between 7% and 14%. Curves were fitted to the data points by eye. All results reported have been confirmed in at least two independent experiments.
For the measurements of intracellular adriamycin concentration, flow cytometry was used (Krishan & Ganapathi, 1980; Durand & Olive, 1981) . It has been shown that this method gives results similar to those obtained by fluorimetry (Chambers et al., 1984 
Results
In Figure 1 ( Figure 2A , where the mean channel N for the emitted fluorescence is plotted against the In order to test whether the potentiation of killing observed after delayed plating of plateau-ADR phase cells was due to a faster clearance of adriamycin from the cells subcultured and incubated in fresh medium after treatment, a set of dishes was treated for 1 h with 10 jug mladriamycin. Half of the dishes were returned after treatment to plateau-phase conditions, whereas the second half was trypsinized and replated (3 x 106 cells/dish) in fresh medium. At various times thereafter, cells were collected and measured for residual, adriamycin-related fluorescence. The results obtained are shown in Figure 2B . A slightly faster decrease of fluorescence was observed for cells trypsinized and plated in fresh medium after treatment. Three hours after treatment, cells in fresh medium showed 40% less fluorescence than cells kept in the plateau-phase, but smaller differences were observed in other experiments. The results presented in the previous section indicate that plateau-phase V79-cells are more resistant to adriamycin than actively growing cells, a result that cannot be entirely explained by the lower intracellular drug accumulation observed (Figure 2 ).
Similar results were also obtained for Chinese hamster ovary cells (Barranco & Novak, 1974; Barranco, 1975) and EMT6 cells (Twentyman & Bleehen, 1975; Sutherland et al., 1979) . The survival curves obtained (Figure 1) Although no difference in the sensitivity to adriamycin of exponentially and plateau-phase cells was found when the results were plotted as survival vs. amount of adriamycin per cell (Sutherland et al., 1979; Chambers et al., 1984) , plateau-phase cells were found to be significantly more resistant to adriamycin than actively growing cells when cell survival was plotted against intracellularly measured adriamycin content (Chambers et al., 1984) . In fact, plateau-phase cells were found to have a higher ability to accumulate adriamycin. Our results also show similar tendencies, indicating a higher accumulation of adriamycin by plateauphase cells, when plotted against the amount of adriamycin per 106 cells (see Figure 2 and consider the cell numbers at the time of the treatment). These findings suggest that not only the intracellular concentration of adriamycin but also other physiological-state-dependent factors may modify the drug cytotoxicity probably by modifying its interaction with the sensitive target(s).
The potentiation of killing observed after delayed plating contrasts with observations made under similar conditions after exposure of mammalian cells to ionizing radiations (e.g., Han & Little, 1972; Iliakis & Pohlit, 1979) . Although this effect could be partly explained by the lower rate of intracellular drug clearance in cells kept in the plateau-phase as indicated in Figure 2 , it is unlikely that this rather small difference in the clearance rate could entirely account for such a dramatic potentiation of killing. It is possible that modifications in the metabolic state of the cells initiated after their incubation in fresh medium affect, in a time dependent way, the pattern of interaction of the sensitive target(s) with adriamycin, thus, changing the cellular response to the drug. Furthermore, other factors such as progression of cells through the cycle, cell-to-cell contact, drug release from the cells into the medium and reabsorption by the survivors may result in the potentiation of killing observed. The influence of these parameters on the observed potentiation of killing, as well as the intracellular distribution of adriamycin in plateau-phase cells incubated in fresh or conditioned medium are presently under study.
It is not known whether the observed potentiation of adriamycin killing is a phenomenon of general validity observed in many different systems, or a peculiarity of the cell line and the conditions used. Hahn et al. (1979) reported no modification in cell survival after delayed plating of refed plateauphase cultures of Chinese hamster cells, but the authors do not specify the time interval examined and the conditions applied; it is possible that refed plateau-phase cultures respond somewhat differently to delayed plating after adriamycin exposure than unfed plateau-phase cultures. We are presently investigating this possibility.
